Literature DB >> 10023320

Telomerase activity and telomere length in human hepatocellular carcinoma.

G T Huang1, H S Lee, C H Chen, L L Chiou, Y W Lin, C Z Lee, D S Chen, J C Sheu.   

Abstract

Telomerase activity is activated and telomere length altered in various types of cancers, including hepatocellular carcinoma (HCC). A total of 39 HCC tissues and the corresponding non-tumour livers were analysed and correlated with clinical parameters. Telomere length was determined by terminal restriction fragment assay, and telomerase activity was assayed by telomeric repeat amplification protocol. Telomerase activity was positive in 24 of the 39 tumour tissues (1.15-285.13 total product generated (TPG) units) and in six of the 39 non-tumour liver tissues (1.05-1.73 TPG units). In the 28 cases analysed for telomere length, telomere length was shortened in 11 cases, lengthened in six cases, and unaltered in 11 cases compared with non-tumour tissues. Neither telomere length nor telomerase activity was correlated to any clinical parameters.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10023320     DOI: 10.1016/s0959-8049(98)00237-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization.

Authors:  Han-Qiang Liu; Jia-Ze An; Juan Liu; Ye-Fa Yang; Hong-Xin Zhang; Bin-Yu Zhao; Ji-Bin Li; Hu-Shan Yang; Zhi-Nan Chen; Jin-Liang Xing
Journal:  Carcinogenesis       Date:  2012-02-08       Impact factor: 4.944

2.  Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.

Authors:  Shaogui Wan; Hie-Won Hann; Zhong Ye; Richard S Hann; Yinzhi Lai; Chun Wang; Ling Li; Ronald E Myers; Bingshan Li; Jinliang Xing; Hushan Yang
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

3.  Over-expression of LPTS-L in hepatocellular carcinoma cell line SMMC-7721 induces crisis.

Authors:  Cheng Liao; Mu-Jun Zhao; Jing Zhao; Di Jia; Hai Song; Zai-Ping Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

4.  Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis.

Authors:  Bong-Kyeong Oh; Young-Joo Kim; Chanil Park; Young Nyun Park
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

5.  Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.

Authors:  Yan-Shen Shan; Yu-Hsiang Hsieh; Pin-Wen Lin
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

6.  Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.

Authors:  Baiyu Yang; Fatma M Shebl; Lawrence R Sternberg; Andrew C Warner; David E Kleiner; Daniel C Edelman; Allison Gomez; Casey L Dagnall; Belynda D Hicks; Sean F Altekruse; Brenda Y Hernandez; Charles F Lynch; Paul S Meltzer; Katherine A McGlynn
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

7.  Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma.

Authors:  Wan Huang; Weiping Zhou; Can Li; Yuan Yang; Yu-Kui Shang; Changsheng Chen; Jing Zhang; Rui Yao; Pei Wang; Wen Wen; Han-Qiang Liu; Ling Wang; Xia Li; Huijie Bian; Zhi-Nan Chen
Journal:  Oncotarget       Date:  2017-04-18

8.  ACYP2 polymorphisms are associated with the risk of liver cancer in a Han Chinese population.

Authors:  Zhong Chen; Yu Sun; Zhenxiong Xu; Junnv Xu; Jingjie Li; Mengdan Yan; Jing Li; Tianbo Jin; Haifeng Lin
Journal:  Oncotarget       Date:  2017-06-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.